---
_id: '10836'
acknowledgement: This  work  was  supported  by  the  Austrian  Science  Fund  (FWF)  grants  MCCA  W1248-B30  and  SFB  F4606-B28  to  EJJ.  CP  received  a  short-term
  research fellowship of the European Federation of Immunological Societies  (EFIS-IL)  for  a  research  visit  at  Biocruces  Bizkaia  Health  Research  Institute,  Barakaldo,  Spain.  VKK  received  an  EFIS-IL  short-term  research  fellowship  for  a  research  visit  at  King’s  College  London.  The
  research was funded by the National Institute for Health Research (NIHR) Biomedical
  Research Centre (BRC) based at Guy's and St Thomas' NHS Foundation Trust and King's
  College London (IS-BRC-1215-20006) (SNK).  The  authors  acknowledge  support  by  the  Medical  Research  Council
  (MR/L023091/1) (SNK); Breast Cancer Now (147; KCL-BCN-Q3)(SNK); Cancer Research
  UK (C30122/A11527; C30122/A15774) (SNK); Cancer  Research  UK  King's  Health  Partners  Centre  at  King's  College  London   (C604/A25135)   (SNK);   CRUK/NIHR   in   England/DoH   for   Scotland,  Wales  and  Northern  Ireland  Experimental  Cancer  Medicine  Centre  (C10355/A15587)  (SNK).  The  views  expressed  are  those  of  the  author(s)  and  not  necessarily  those  of  the  NHS,  the  NIHR  or  the  Department  of  Health.  Additionally,  this  work  was  funded  by  Instituto  de  Salud  Carlos  III  through  the  project  "PI16/01223"  (Co-funded  by  European
  Regional Development Fund; “A way to make Europe”) to FB and  by  the  Department  of  Health,  Basque  Government  through  the  project
  “2019111031” to OZ. OZ is recipient of a Sara Borrell 2017 post-doctoral contract
  “CD17/00128” funded by Instituto de Salud Carlos III (Co-funded by European Social
  Fund; “Investing in your future”).
article_processing_charge: No
article_type: letter_note
author:
- first_name: Christina L.
  full_name: Pranger, Christina L.
  last_name: Pranger
- first_name: Judit
  full_name: Fazekas-Singer, Judit
  id: 36432834-F248-11E8-B48F-1D18A9856A87
  last_name: Fazekas-Singer
  orcid: 0000-0002-8777-3502
- first_name: Verena K.
  full_name: Köhler, Verena K.
  last_name: Köhler
- first_name: Isabella
  full_name: Pali‐Schöll, Isabella
  last_name: Pali‐Schöll
- first_name: Alessandro
  full_name: Fiocchi, Alessandro
  last_name: Fiocchi
- first_name: Sophia N.
  full_name: Karagiannis, Sophia N.
  last_name: Karagiannis
- first_name: Olatz
  full_name: Zenarruzabeitia, Olatz
  last_name: Zenarruzabeitia
- first_name: Francisco
  full_name: Borrego, Francisco
  last_name: Borrego
- first_name: Erika
  full_name: Jensen‐Jarolim, Erika
  last_name: Jensen‐Jarolim
citation:
  ama: 'Pranger CL, Singer J, Köhler VK, et al. PIPE‐cloned human IgE and IgG4 antibodies:
    New tools for investigating cow’s milk allergy and tolerance. <i>Allergy</i>.
    2021;76(5):1553-1556. doi:<a href="https://doi.org/10.1111/all.14604">10.1111/all.14604</a>'
  apa: 'Pranger, C. L., Singer, J., Köhler, V. K., Pali‐Schöll, I., Fiocchi, A., Karagiannis,
    S. N., … Jensen‐Jarolim, E. (2021). PIPE‐cloned human IgE and IgG4 antibodies:
    New tools for investigating cow’s milk allergy and tolerance. <i>Allergy</i>.
    Wiley. <a href="https://doi.org/10.1111/all.14604">https://doi.org/10.1111/all.14604</a>'
  chicago: 'Pranger, Christina L., Judit Singer, Verena K. Köhler, Isabella Pali‐Schöll,
    Alessandro Fiocchi, Sophia N. Karagiannis, Olatz Zenarruzabeitia, Francisco Borrego,
    and Erika Jensen‐Jarolim. “PIPE‐cloned Human IgE and IgG4 Antibodies: New Tools
    for Investigating Cow’s Milk Allergy and Tolerance.” <i>Allergy</i>. Wiley, 2021.
    <a href="https://doi.org/10.1111/all.14604">https://doi.org/10.1111/all.14604</a>.'
  ieee: 'C. L. Pranger <i>et al.</i>, “PIPE‐cloned human IgE and IgG4 antibodies:
    New tools for investigating cow’s milk allergy and tolerance,” <i>Allergy</i>,
    vol. 76, no. 5. Wiley, pp. 1553–1556, 2021.'
  ista: 'Pranger CL, Singer J, Köhler VK, Pali‐Schöll I, Fiocchi A, Karagiannis SN,
    Zenarruzabeitia O, Borrego F, Jensen‐Jarolim E. 2021. PIPE‐cloned human IgE and
    IgG4 antibodies: New tools for investigating cow’s milk allergy and tolerance.
    Allergy. 76(5), 1553–1556.'
  mla: 'Pranger, Christina L., et al. “PIPE‐cloned Human IgE and IgG4 Antibodies:
    New Tools for Investigating Cow’s Milk Allergy and Tolerance.” <i>Allergy</i>,
    vol. 76, no. 5, Wiley, 2021, pp. 1553–56, doi:<a href="https://doi.org/10.1111/all.14604">10.1111/all.14604</a>.'
  short: C.L. Pranger, J. Singer, V.K. Köhler, I. Pali‐Schöll, A. Fiocchi, S.N. Karagiannis,
    O. Zenarruzabeitia, F. Borrego, E. Jensen‐Jarolim, Allergy 76 (2021) 1553–1556.
date_created: 2022-03-08T11:19:05Z
date_published: 2021-05-01T00:00:00Z
date_updated: 2023-09-05T15:58:53Z
day: '01'
ddc:
- '570'
department:
- _id: Bio
doi: 10.1111/all.14604
external_id:
  isi:
  - '000577708800001'
  pmid:
  - '32990982'
file:
- access_level: open_access
  checksum: 9526f9554112fc027c9f7fa540c488cd
  content_type: application/pdf
  creator: dernst
  date_created: 2022-03-08T11:23:16Z
  date_updated: 2022-03-08T11:23:16Z
  file_id: '10837'
  file_name: 2021_Allergy_Pranger.pdf
  file_size: 626081
  relation: main_file
  success: 1
file_date_updated: 2022-03-08T11:23:16Z
has_accepted_license: '1'
intvolume: '        76'
isi: 1
issue: '5'
keyword:
- Immunology
- Immunology and Allergy
language:
- iso: eng
month: '05'
oa: 1
oa_version: Published Version
page: 1553-1556
pmid: 1
publication: Allergy
publication_identifier:
  eissn:
  - 1398-9995
  issn:
  - 0105-4538
publication_status: published
publisher: Wiley
quality_controlled: '1'
scopus_import: '1'
status: public
title: 'PIPE‐cloned human IgE and IgG4 antibodies: New tools for investigating cow''s
  milk allergy and tolerance'
tmp:
  image: /images/cc_by.png
  legal_code_url: https://creativecommons.org/licenses/by/4.0/legalcode
  name: Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)
  short: CC BY (4.0)
type: journal_article
user_id: c635000d-4b10-11ee-a964-aac5a93f6ac1
volume: 76
year: '2021'
...
---
_id: '8226'
article_processing_charge: No
article_type: letter_note
author:
- first_name: Jelena
  full_name: Gotovina, Jelena
  last_name: Gotovina
  orcid: 0000-0003-1503-5276
- first_name: Rodolfo
  full_name: Bianchini, Rodolfo
  last_name: Bianchini
  orcid: 0000-0003-0351-6937
- first_name: Judit
  full_name: Fazekas-Singer, Judit
  id: 36432834-F248-11E8-B48F-1D18A9856A87
  last_name: Fazekas-Singer
  orcid: 0000-0002-8777-3502
- first_name: Ina
  full_name: Herrmann, Ina
  last_name: Herrmann
  orcid: 0000-0003-2772-9144
- first_name: Giulia
  full_name: Pellizzari, Giulia
  last_name: Pellizzari
  orcid: 0000-0003-0387-1912
- first_name: Ian D.
  full_name: Haidl, Ian D.
  last_name: Haidl
  orcid: 0000-0002-5301-0822
- first_name: Karin
  full_name: Hufnagl, Karin
  last_name: Hufnagl
  orcid: 0000-0002-2288-2468
- first_name: Sophia N.
  full_name: Karagiannis, Sophia N.
  last_name: Karagiannis
  orcid: 0000-0002-4100-7810
- first_name: Jean S.
  full_name: Marshall, Jean S.
  last_name: Marshall
  orcid: 0000-0002-5642-1379
- first_name: Erika
  full_name: Jensen‐Jarolim, Erika
  last_name: Jensen‐Jarolim
  orcid: 0000-0003-4019-5765
citation:
  ama: Gotovina J, Bianchini R, Singer J, et al. Epinephrine drives human M2a allergic
    macrophages to a regulatory phenotype reducing mast cell degranulation in vitro.
    <i>Allergy</i>. 2020. doi:<a href="https://doi.org/10.1111/all.14299">10.1111/all.14299</a>
  apa: Gotovina, J., Bianchini, R., Singer, J., Herrmann, I., Pellizzari, G., Haidl,
    I. D., … Jensen‐Jarolim, E. (2020). Epinephrine drives human M2a allergic macrophages
    to a regulatory phenotype reducing mast cell degranulation in vitro. <i>Allergy</i>.
    Wiley. <a href="https://doi.org/10.1111/all.14299">https://doi.org/10.1111/all.14299</a>
  chicago: Gotovina, Jelena, Rodolfo Bianchini, Judit Singer, Ina Herrmann, Giulia
    Pellizzari, Ian D. Haidl, Karin Hufnagl, Sophia N. Karagiannis, Jean S. Marshall,
    and Erika Jensen‐Jarolim. “Epinephrine Drives Human M2a Allergic Macrophages to
    a Regulatory Phenotype Reducing Mast Cell Degranulation in Vitro.” <i>Allergy</i>.
    Wiley, 2020. <a href="https://doi.org/10.1111/all.14299">https://doi.org/10.1111/all.14299</a>.
  ieee: J. Gotovina <i>et al.</i>, “Epinephrine drives human M2a allergic macrophages
    to a regulatory phenotype reducing mast cell degranulation in vitro,” <i>Allergy</i>.
    Wiley, 2020.
  ista: Gotovina J, Bianchini R, Singer J, Herrmann I, Pellizzari G, Haidl ID, Hufnagl
    K, Karagiannis SN, Marshall JS, Jensen‐Jarolim E. 2020. Epinephrine drives human
    M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation
    in vitro. Allergy.
  mla: Gotovina, Jelena, et al. “Epinephrine Drives Human M2a Allergic Macrophages
    to a Regulatory Phenotype Reducing Mast Cell Degranulation in Vitro.” <i>Allergy</i>,
    Wiley, 2020, doi:<a href="https://doi.org/10.1111/all.14299">10.1111/all.14299</a>.
  short: J. Gotovina, R. Bianchini, J. Singer, I. Herrmann, G. Pellizzari, I.D. Haidl,
    K. Hufnagl, S.N. Karagiannis, J.S. Marshall, E. Jensen‐Jarolim, Allergy (2020).
date_created: 2020-08-10T11:50:30Z
date_published: 2020-04-04T00:00:00Z
date_updated: 2021-01-12T08:17:35Z
day: '04'
doi: 10.1111/all.14299
extern: '1'
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://doi.org/10.1111/all.14299
month: '04'
oa: 1
oa_version: Published Version
publication: Allergy
publication_identifier:
  issn:
  - 0105-4538
  - 1398-9995
publication_status: epub_ahead
publisher: Wiley
quality_controlled: '1'
status: public
title: Epinephrine drives human M2a allergic macrophages to a regulatory phenotype
  reducing mast cell degranulation in vitro
type: journal_article
user_id: 2DF688A6-F248-11E8-B48F-1D18A9856A87
year: '2020'
...
---
_id: '8227'
article_processing_charge: No
article_type: letter_note
author:
- first_name: Kristina M.
  full_name: Ilieva, Kristina M.
  last_name: Ilieva
- first_name: Judit
  full_name: Fazekas-Singer, Judit
  id: 36432834-F248-11E8-B48F-1D18A9856A87
  last_name: Fazekas-Singer
  orcid: 0000-0002-8777-3502
- first_name: Heather J.
  full_name: Bax, Heather J.
  last_name: Bax
- first_name: Silvia
  full_name: Crescioli, Silvia
  last_name: Crescioli
- first_name: Laura
  full_name: Montero‐Morales, Laura
  last_name: Montero‐Morales
- first_name: Silvia
  full_name: Mele, Silvia
  last_name: Mele
- first_name: Heng Sheng
  full_name: Sow, Heng Sheng
  last_name: Sow
- first_name: Chara
  full_name: Stavraka, Chara
  last_name: Stavraka
- first_name: Debra H.
  full_name: Josephs, Debra H.
  last_name: Josephs
- first_name: James F.
  full_name: Spicer, James F.
  last_name: Spicer
- first_name: Herta
  full_name: Steinkellner, Herta
  last_name: Steinkellner
  orcid: 0000-0003-4823-1505
- first_name: Erika
  full_name: Jensen‐Jarolim, Erika
  last_name: Jensen‐Jarolim
  orcid: 0000-0003-4019-5765
- first_name: Andrew N. J.
  full_name: Tutt, Andrew N. J.
  last_name: Tutt
  orcid: 0000-0001-8715-2901
- first_name: Sophia N.
  full_name: Karagiannis, Sophia N.
  last_name: Karagiannis
  orcid: 0000-0002-4100-7810
citation:
  ama: 'Ilieva KM, Singer J, Bax HJ, et al. AllergoOncology: Expression platform development
    and functional profiling of an anti‐HER2 IgE antibody. <i>Allergy</i>. 2019;74(10):1985-1989.
    doi:<a href="https://doi.org/10.1111/all.13818">10.1111/all.13818</a>'
  apa: 'Ilieva, K. M., Singer, J., Bax, H. J., Crescioli, S., Montero‐Morales, L.,
    Mele, S., … Karagiannis, S. N. (2019). AllergoOncology: Expression platform development
    and functional profiling of an anti‐HER2 IgE antibody. <i>Allergy</i>. Wiley.
    <a href="https://doi.org/10.1111/all.13818">https://doi.org/10.1111/all.13818</a>'
  chicago: 'Ilieva, Kristina M., Judit Singer, Heather J. Bax, Silvia Crescioli, Laura
    Montero‐Morales, Silvia Mele, Heng Sheng Sow, et al. “AllergoOncology: Expression
    Platform Development and Functional Profiling of an Anti‐HER2 IgE Antibody.” <i>Allergy</i>.
    Wiley, 2019. <a href="https://doi.org/10.1111/all.13818">https://doi.org/10.1111/all.13818</a>.'
  ieee: 'K. M. Ilieva <i>et al.</i>, “AllergoOncology: Expression platform development
    and functional profiling of an anti‐HER2 IgE antibody,” <i>Allergy</i>, vol. 74,
    no. 10. Wiley, pp. 1985–1989, 2019.'
  ista: 'Ilieva KM, Singer J, Bax HJ, Crescioli S, Montero‐Morales L, Mele S, Sow
    HS, Stavraka C, Josephs DH, Spicer JF, Steinkellner H, Jensen‐Jarolim E, Tutt
    ANJ, Karagiannis SN. 2019. AllergoOncology: Expression platform development and
    functional profiling of an anti‐HER2 IgE antibody. Allergy. 74(10), 1985–1989.'
  mla: 'Ilieva, Kristina M., et al. “AllergoOncology: Expression Platform Development
    and Functional Profiling of an Anti‐HER2 IgE Antibody.” <i>Allergy</i>, vol. 74,
    no. 10, Wiley, 2019, pp. 1985–89, doi:<a href="https://doi.org/10.1111/all.13818">10.1111/all.13818</a>.'
  short: K.M. Ilieva, J. Singer, H.J. Bax, S. Crescioli, L. Montero‐Morales, S. Mele,
    H.S. Sow, C. Stavraka, D.H. Josephs, J.F. Spicer, H. Steinkellner, E. Jensen‐Jarolim,
    A.N.J. Tutt, S.N. Karagiannis, Allergy 74 (2019) 1985–1989.
date_created: 2020-08-10T11:50:42Z
date_published: 2019-10-01T00:00:00Z
date_updated: 2021-01-12T08:17:35Z
day: '01'
doi: 10.1111/all.13818
extern: '1'
intvolume: '        74'
issue: '10'
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://doi.org/10.1111/all.13818
month: '10'
oa: 1
oa_version: Published Version
page: 1985-1989
publication: Allergy
publication_identifier:
  issn:
  - 0105-4538
  - 1398-9995
publication_status: published
publisher: Wiley
quality_controlled: '1'
status: public
title: 'AllergoOncology: Expression platform development and functional profiling
  of an anti‐HER2 IgE antibody'
type: journal_article
user_id: 2DF688A6-F248-11E8-B48F-1D18A9856A87
volume: 74
year: '2019'
...
---
_id: '8236'
abstract:
- lang: eng
  text: Th2 immunity and allergic immune surveillance play critical roles in host
    responses to pathogens, parasites and allergens. Numerous studies have reported
    significant links between Th2 responses and cancer, including insights into the
    functions of IgE antibodies and associated effector cells in both antitumour immune
    surveillance and therapy. The interdisciplinary field of AllergoOncology was given
    Task Force status by the European Academy of Allergy and Clinical Immunology in
    2014. Affiliated expert groups focus on the interface between allergic responses
    and cancer, applied to immune surveillance, immunomodulation and the functions
    of IgE‐mediated immune responses against cancer, to derive novel insights into
    more effective treatments. Coincident with rapid expansion in clinical application
    of cancer immunotherapies, here we review the current state‐of‐the‐art and future
    translational opportunities, as well as challenges in this relatively new field.
    Recent developments include improved understanding of Th2 antibodies, intratumoral
    innate allergy effector cells and mediators, IgE‐mediated tumour antigen cross‐presentation
    by dendritic cells, as well as immunotherapeutic strategies such as vaccines and
    recombinant antibodies, and finally, the management of allergy in daily clinical
    oncology. Shedding light on the crosstalk between allergic response and cancer
    is paving the way for new avenues of treatment.
article_processing_charge: No
article_type: original
author:
- first_name: E.
  full_name: Jensen-Jarolim, E.
  last_name: Jensen-Jarolim
  orcid: 0000-0003-4019-5765
- first_name: H. J.
  full_name: Bax, H. J.
  last_name: Bax
- first_name: R.
  full_name: Bianchini, R.
  last_name: Bianchini
- first_name: M.
  full_name: Capron, M.
  last_name: Capron
- first_name: C.
  full_name: Corrigan, C.
  last_name: Corrigan
- first_name: M.
  full_name: Castells, M.
  last_name: Castells
- first_name: D.
  full_name: Dombrowicz, D.
  last_name: Dombrowicz
- first_name: T. R.
  full_name: Daniels-Wells, T. R.
  last_name: Daniels-Wells
- first_name: Judit
  full_name: Fazekas, Judit
  id: 36432834-F248-11E8-B48F-1D18A9856A87
  last_name: Fazekas
  orcid: 0000-0002-8777-3502
- first_name: E.
  full_name: Fiebiger, E.
  last_name: Fiebiger
- first_name: S.
  full_name: Gatault, S.
  last_name: Gatault
- first_name: H. J.
  full_name: Gould, H. J.
  last_name: Gould
- first_name: J.
  full_name: Janda, J.
  last_name: Janda
- first_name: D. H.
  full_name: Josephs, D. H.
  last_name: Josephs
- first_name: P.
  full_name: Karagiannis, P.
  last_name: Karagiannis
- first_name: F.
  full_name: Levi-Schaffer, F.
  last_name: Levi-Schaffer
- first_name: A.
  full_name: Meshcheryakova, A.
  last_name: Meshcheryakova
- first_name: D.
  full_name: Mechtcheriakova, D.
  last_name: Mechtcheriakova
- first_name: Y.
  full_name: Mekori, Y.
  last_name: Mekori
- first_name: F.
  full_name: Mungenast, F.
  last_name: Mungenast
- first_name: E. A.
  full_name: Nigro, E. A.
  last_name: Nigro
- first_name: M. L.
  full_name: Penichet, M. L.
  last_name: Penichet
- first_name: F.
  full_name: Redegeld, F.
  last_name: Redegeld
- first_name: L.
  full_name: Saul, L.
  last_name: Saul
- first_name: J.
  full_name: Singer, J.
  last_name: Singer
- first_name: J. F.
  full_name: Spicer, J. F.
  last_name: Spicer
- first_name: A. G.
  full_name: Siccardi, A. G.
  last_name: Siccardi
- first_name: E.
  full_name: Spillner, E.
  last_name: Spillner
- first_name: M. C.
  full_name: Turner, M. C.
  last_name: Turner
- first_name: E.
  full_name: Untersmayr, E.
  last_name: Untersmayr
- first_name: L.
  full_name: Vangelista, L.
  last_name: Vangelista
- first_name: S. N.
  full_name: Karagiannis, S. N.
  last_name: Karagiannis
citation:
  ama: 'Jensen-Jarolim E, Bax HJ, Bianchini R, et al. AllergoOncology - the impact
    of allergy in oncology: EAACI position paper. <i>Allergy</i>. 2017;72(6):866-887.
    doi:<a href="https://doi.org/10.1111/all.13119">10.1111/all.13119</a>'
  apa: 'Jensen-Jarolim, E., Bax, H. J., Bianchini, R., Capron, M., Corrigan, C., Castells,
    M., … Karagiannis, S. N. (2017). AllergoOncology - the impact of allergy in oncology:
    EAACI position paper. <i>Allergy</i>. Wiley. <a href="https://doi.org/10.1111/all.13119">https://doi.org/10.1111/all.13119</a>'
  chicago: 'Jensen-Jarolim, E., H. J. Bax, R. Bianchini, M. Capron, C. Corrigan, M.
    Castells, D. Dombrowicz, et al. “AllergoOncology - the Impact of Allergy in Oncology:
    EAACI Position Paper.” <i>Allergy</i>. Wiley, 2017. <a href="https://doi.org/10.1111/all.13119">https://doi.org/10.1111/all.13119</a>.'
  ieee: 'E. Jensen-Jarolim <i>et al.</i>, “AllergoOncology - the impact of allergy
    in oncology: EAACI position paper,” <i>Allergy</i>, vol. 72, no. 6. Wiley, pp.
    866–887, 2017.'
  ista: 'Jensen-Jarolim E, Bax HJ, Bianchini R, Capron M, Corrigan C, Castells M,
    Dombrowicz D, Daniels-Wells TR, Singer J, Fiebiger E, Gatault S, Gould HJ, Janda
    J, Josephs DH, Karagiannis P, Levi-Schaffer F, Meshcheryakova A, Mechtcheriakova
    D, Mekori Y, Mungenast F, Nigro EA, Penichet ML, Redegeld F, Saul L, Singer J,
    Spicer JF, Siccardi AG, Spillner E, Turner MC, Untersmayr E, Vangelista L, Karagiannis
    SN. 2017. AllergoOncology - the impact of allergy in oncology: EAACI position
    paper. Allergy. 72(6), 866–887.'
  mla: 'Jensen-Jarolim, E., et al. “AllergoOncology - the Impact of Allergy in Oncology:
    EAACI Position Paper.” <i>Allergy</i>, vol. 72, no. 6, Wiley, 2017, pp. 866–87,
    doi:<a href="https://doi.org/10.1111/all.13119">10.1111/all.13119</a>.'
  short: E. Jensen-Jarolim, H.J. Bax, R. Bianchini, M. Capron, C. Corrigan, M. Castells,
    D. Dombrowicz, T.R. Daniels-Wells, J. Singer, E. Fiebiger, S. Gatault, H.J. Gould,
    J. Janda, D.H. Josephs, P. Karagiannis, F. Levi-Schaffer, A. Meshcheryakova, D.
    Mechtcheriakova, Y. Mekori, F. Mungenast, E.A. Nigro, M.L. Penichet, F. Redegeld,
    L. Saul, J. Singer, J.F. Spicer, A.G. Siccardi, E. Spillner, M.C. Turner, E. Untersmayr,
    L. Vangelista, S.N. Karagiannis, Allergy 72 (2017) 866–887.
date_created: 2020-08-10T11:53:26Z
date_published: 2017-06-01T00:00:00Z
date_updated: 2021-01-12T08:17:39Z
day: '01'
doi: 10.1111/all.13119
extern: '1'
intvolume: '        72'
issue: '6'
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://doi.org/10.1111/all.13119
month: '06'
oa: 1
oa_version: Published Version
page: 866-887
publication: Allergy
publication_identifier:
  issn:
  - 0105-4538
publication_status: published
publisher: Wiley
quality_controlled: '1'
status: public
title: 'AllergoOncology - the impact of allergy in oncology: EAACI position paper'
type: journal_article
user_id: 2DF688A6-F248-11E8-B48F-1D18A9856A87
volume: 72
year: '2017'
...
